Currently I work at:

But as of close of business on Wednesday June 30th, I will be working for:
Who would have thought when I started at Myriad 13 1/2 years ago when I was about employee 100, that Myriad would grow to almost 1000 employees, have spun off a privately held company Prolexys, and would soon spin off a completely independent, publicly traded company. I was there in the early days of the ground breaking genetic testing, helped to automate a protein-protein interaction system, helped automate and design the high throughput sequencing facility that sequenced rice, corn, and grape genomes, was in awe of the group that helped with the DNA identification of World Trade Center remains after 9/11, and had such high hopes for our Alzheimer's drug that ended up failing miserably in clinical trials. It's been a crazy, wild, and often a really incredible ride. Thanks Myriad and here's to our continued success...




